| Q52712450 | A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. |
| Q49582395 | A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. |
| Q55040580 | A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injecti |
| Q39306224 | A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach. |
| Q37192444 | A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system |
| Q37489730 | Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations |
| Q33552684 | Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden |
| Q49570488 | Adoption Barriers for Continuous Glucose Monitoring and Their Potential Reduction With a Fully Implanted System: Results From Patient Preference Surveys |
| Q90733537 | Advances in Type 1 Diabetes Technology Over the Last Decade |
| Q37972359 | Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps |
| Q90166958 | Advances in technology for management of type 1 diabetes |
| Q39159963 | Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population. |
| Q38991285 | An alternative sensor-based method for glucose monitoring in children and young people with diabetes |
| Q36340531 | Analysis: The Accuracy and Efficacy of the Dexcom G4 Platinum Continuous Glucose Monitoring System. |
| Q36638904 | Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies? |
| Q93115321 | Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents |
| Q34151693 | Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol |
| Q35898281 | Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study |
| Q52642816 | Automated Insulin Delivery Systems: Hopes and Expectations of Family Members. |
| Q38262799 | Banting Memorial Lecture 2014* Technology and diabetes care: appropriate and personalized |
| Q90681483 | Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring |
| Q64063605 | Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System |
| Q33727481 | Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes |
| Q42245193 | Clinical Use of Continuous Glucose Monitoring in Pediatrics |
| Q37280510 | Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study |
| Q34511505 | Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial) |
| Q55410104 | Consistency of Continuous Ambulatory Interstitial Glucose Monitoring Sensors. |
| Q36683323 | Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen |
| Q39974199 | Continuous Glucose Monitoring Adherence: Lessons From a Clinical Trial to Predict Outpatient Behavior |
| Q53423259 | Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes. |
| Q88265830 | Continuous Glucose Monitoring Efficacy in Routine Use |
| Q92807720 | Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications |
| Q50233514 | Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization |
| Q33786148 | Continuous Glucose Monitoring and Global Reimbursement: An Update |
| Q50695500 | Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial. |
| Q33786220 | Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies |
| Q38763554 | Continuous Glucose Monitoring: A Perspective on Its Past, Present, and Future Applications for Diabetes Management |
| Q57164680 | Continuous Glucose Monitoring: Current Use in Diabetes Management and Possible Future Applications |
| Q41662919 | Continuous Glucose Monitoring: Impact on Hypoglycemia. |
| Q37921897 | Continuous blood glucose monitoring in diabetes treatment |
| Q42019244 | Continuous glucose monitoring and trend accuracy: news about a trend compass |
| Q39376348 | Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. |
| Q37577292 | Continuous glucose monitoring in 2013. |
| Q38025974 | Continuous glucose monitoring in children and adolescents |
| Q46480535 | Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria |
| Q47216039 | Continuous glucose monitoring in type 1 diabetes |
| Q24203866 | Continuous glucose monitoring systems for type 1 diabetes mellitus |
| Q27022628 | Continuous glucose monitoring: evidence and consensus statement for clinical use |
| Q35682809 | Continuous glucose monitors: use of waveform versus glycemic values in the improvements of glucose control, quality of life, and fear of hypoglycemia |
| Q35751626 | Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia |
| Q99631215 | Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring |
| Q37275395 | Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM). |
| Q45044961 | Effectiveness of continuous glucose monitoring in children, adolescents, and young adults with poorly controlled type 1 diabetes |
| Q53553958 | Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial. |
| Q37972356 | Emergent technologies applied to diabetes: what do we need to integrate continuous glucose monitoring into daily practice? Where the long-term use of continuous glucose monitoring stands in 2011. |
| Q37424166 | Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring |
| Q48137451 | Evaluation of glucose control when a new strategy of increased carbohydrate supply is implemented during prolonged physical exercise in type 1 diabetes |
| Q37429130 | Evaluation of the performance of a novel system for continuous glucose monitoring |
| Q38154975 | Evidence for continuous glucose monitoring: sufficient for reimbursement? |
| Q51337164 | Fasting glucose level is associated with nocturnal hypoglycemia in elderly male patients with type 2 diabetes. |
| Q26865375 | Fluorescence intensity- and lifetime-based glucose sensing using glucose/galactose-binding protein |
| Q92841831 | GLUCOSE CHANGES IN A PATIENT WITH INSULIN AUTOIMMUNE SYNDROME DEMONSTRATED BY CONTINUOUS GLUCOSE MONITORING |
| Q88271569 | Glucose sensing technology-current practice? |
| Q36159100 | High reported treatment satisfaction in people with type 1 diabetes switching to latest generation insulin pump regardless of previous therapy |
| Q54855584 | How Much Accuracy of Interstitial Glucose Measurement Is Enough? Is There a Need for New Evidence? |
| Q37972355 | How technology has changed diabetes management and what it has failed to achieve |
| Q36159014 | HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Da |
| Q57412905 | Hypoglycaemia unawareness |
| Q93339143 | Hypoglycemia and its management in primary care setting |
| Q37991762 | Hypoglycemia in critically ill children |
| Q37890785 | Hypoglycemia in insulin-treated diabetes: a case for increased vigilance |
| Q43693333 | Hypoglycemia in patients with diabetes who are fasting for laboratory blood tests: the Cape Girardeau Hypoglycemia En Route Prevention Program |
| Q92174720 | Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study |
| Q36638881 | Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One Year |
| Q49228447 | Impact of Insulin Delivery Method on Hypoglycemia Incidence in Pediatric Type 1 Diabetes Mellitus Patients |
| Q47222876 | Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial. |
| Q42050177 | In-vitro performance of the Enlite Sensor in various glucose concentrations during hypobaric and hyperbaric conditions |
| Q38205861 | Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems |
| Q30409109 | Insulin therapy and hypoglycemia |
| Q89002574 | Interstitium versus Blood Equilibrium in Glucose Concentration and its Impact on Subcutaneous Continuous Glucose Monitoring Systems |
| Q30458979 | Italian contributions to the development of continuous glucose monitoring sensors for diabetes management |
| Q49887494 | Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes |
| Q28071536 | Knowledge of health principles among professionals in Slovenian kindergartens |
| Q35682802 | Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy |
| Q37988797 | Management of diabetes mellitus: is the pump mightier than the pen? |
| Q38580509 | Multiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient-An Evidence-based Approach. |
| Q38734994 | Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions |
| Q38820633 | Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial |
| Q37192453 | Physical activity measured by physical activity monitoring system correlates with glucose trends reconstructed from continuous glucose monitoring |
| Q36605837 | Pilot study of a prototype minimally invasive intradermal continuous glucose monitor |
| Q38861400 | Psychosocial Aspects of Continuous Glucose Monitoring: Connecting to the Patients' Experience |
| Q92327854 | REAL-WORLD IMPLICATIONS OF HYBRID CLOSE LOOP (HCL) INSULIN DELIVERY SYSTEM |
| Q45112208 | REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes |
| Q42975760 | Rapid improvement in blood glucose control in a patient with type 1 diabetes and complete blindness using a continuous glucose monitor |
| Q38855321 | Real-Time Continuous Glucose Monitoring Facilitates Feelings of Safety in Older Adults With Type 1 Diabetes: A Qualitative Study |
| Q84974726 | Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE |
| Q35360823 | Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry |
| Q49834635 | Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial |
| Q36720416 | Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept |
| Q51744512 | Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians. |
| Q38155773 | Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. |
| Q27687563 | Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile |
| Q38702535 | Reimbursement for Continuous Glucose Monitoring |
| Q40982460 | Reliability of Trained Dogs to Alert to Hypoglycemia in Patients With Type 1 Diabetes |
| Q26769878 | Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement |
| Q37331320 | Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial |
| Q38771704 | Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting |
| Q88868484 | Role of continuous glucose monitoring in the management of glycogen storage disorders |
| Q36554596 | Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus |
| Q24186492 | Screening with urinary dipsticks for reducing morbidity and mortality |
| Q47114356 | Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy |
| Q38159475 | Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention. |
| Q35620189 | Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes |
| Q24632533 | Standards of medical care in diabetes--2012 |
| Q58709957 | Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study |
| Q56516887 | Technology in the management of type 1 diabetes mellitus - current status and future prospects |
| Q46487438 | The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial |
| Q37288519 | The Contemporary Role of Masked Continuous Glucose Monitoring in a Real-Time World |
| Q37054667 | The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes |
| Q38658266 | The Development of New Composite Metrics for the Comprehensive Analytic and Visual Assessment of Hypoglycemia Using the Hypo-Triad |
| Q88312388 | The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes |
| Q36291631 | The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System |
| Q37054685 | The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring |
| Q88312391 | The Rationale for Continuous Glucose Monitoring-based Diabetes Treatment Decisions and Non-adjunctive Continuous Glucose Monitoring Use |
| Q91066310 | The Role of Physical Exercise in Obesity and Diabetes |
| Q30421548 | The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes |
| Q36159119 | The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus |
| Q35682794 | The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trial |
| Q38725717 | The rise of technology in diabetes care. Not all that is new is necessarily better |
| Q36777662 | The role of continuous glucose monitoring in the care of children with type 1 diabetes |
| Q36353388 | The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial |
| Q38959162 | Type 1 Diabetes in the Young: Organization of Two National Centers in Israel and Slovenia |
| Q48247674 | Unexpected Management Behaviors in Adolescents With Type 1 Diabetes Using Sensor-Augmented Pump Therapy. |
| Q36475919 | Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring |
| Q36281766 | Use of continuous glucose monitoring as an outcome measure in clinical trials |
| Q37979361 | Use of continuous glucose monitoring in children and adolescents (*). |